sanofi

Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines.

Two of the world’s biggest drug companies — Sanofi Pasteur and GSK — are combining forces to hopefully speed development of a vaccine for COVID-19.